Sort by
Refine Your Search
-
for up-to-date information. Dr Louisa Alessandri (1963-1997) was diagnosed with muscular dystrophy at an early age. This did not stop her from progressing through her academic career, gaining a BSc
-
School’s Biostatistics team and the Keele Health and Care Data Research Network on a study funded by Muscular Dystrophy UK. You will have a PhD in epidemiology, biostatistics or other related subject with a
-
wellbeing initiatives to support you. Closing Date: 19 October 2026 The Role You will join the John Walton Muscular Dystrophy Research Centre, an internationally recognised centre of excellence in
-
muscle transcriptome. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2
-
muscle transcriptome. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2
-
growing number of neurodegenerative and neuromuscular disorders, including amyotrophic lateral sclerosis (ALS) and myotonic dystrophy (DM). Despite their importance in disease, the mechanisms through which
-
, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London
-
, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1
-
myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites
-
molecular and cellular dysfunction. These RNAs contribute to a growing number of neurodegenerative and neuromuscular disorders, including amyotrophic lateral sclerosis (ALS) and myotonic dystrophy (DM